MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of investments
$178,500K
Proceeds from issuance of
common stock for...
$8,639K
Proceeds from issuance of
common stock for...
$3,182K
Proceeds from employee
stock purchase plan
$615K
Proceeds from sale of prv
$150,000K
Disposals of property and
equipment
$448K
Net cash provided by
(used in) investing...
$18,127K
Net cash provided by
financing activities
$12,064K
Canceled cashflow
$310,821K
Effect of exchange rate
changes on cash and cash...
$28K
Canceled cashflow
$372K
Other (income)
expense, net
-$133,735K
Revenue, net
$106,470K
Interest income
$7,573K
Net increase
(decrease) in cash and cash...
$28,621K
Canceled cashflow
$1,598K
Purchases of investments
$309,986K
Purchases of property and
equipment
$835K
Payments of principal on
insurance financing...
$372K
Net income (loss)
$83,229K
Impairment of intangible
assets
$58,710K
Stock-based compensation
expense
$12,634K
Inventory obsolescence
charge
$11,681K
Discount and rebate
liabilities
$6,683K
Depreciation and
amortization expense
$4,054K
Income tax expense
$3,449K
Non-cash interest
expense
$2,649K
Loss on foreign
currency exchange rates
-$1,548K
Non-cash lease expense
$602K
Other long-term
assets
-$451K
Consulting fees paid in
common stock
$75K
Loss on sublease and
disposal of property and...
$63K
Canceled cashflow
$164,549K
Net cash used in
operating activities
-$1,598K
Canceled cashflow
$185,828K
Impairment of intangible
assets
$58,710K
Selling, general and
administrative identified to...
$50,861K
Selling, general and
administrative identified to...
$26,755K
Interest expense
$7,977K
Research and development
directly identified to...
$7,710K
Research and development
directly identified to...
$5,033K
Depreciation and
amortization expense
$4,054K
Income tax expense
$3,449K
Gain on sale of prv
$148,325K
Accounts payable and
accrued expenses
-$15,587K
Accounts and other
receivables
$11,977K
Accretion on investments
$3,128K
Prepaid expenses and
other current assets
$2,943K
Fair value
adjustment related to...
-$2,178K
Inventories
$1,305K
Other liabilities
-$1,159K
Operating lease
liabilities
-$675K
Fair value
adjustment related to...
-$149K
Back
Back
Cash Flow
source: myfinsight.com
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)